HLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT05102214 · UNKNOWN

Trial details

NCT number: NCT05102214
Sponsor: Shanghai Henlius Biotech
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors Non-small Cell Lung Cancer

Start date: 2022-05-03
Primary completion: 2023-09-15
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.